Search Results 1101-1110 of 2028 for Filler Frontier
Latest stories ; Z-endoxifen shows promise as new treatment for common breast cancer type featured image. Cancer ; Discovery's Edge: Dementia mysteries untangled ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed and tested a new 3D surface scanning approach that gives neurosurgeons even greater precision when ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
Marla Broadfoot, Ph.D. February 23, 2026. Mayo Clinic study identifies mechanism behind immunotherapy resistance in lung cancer featured image.
Mayo Clinic uses gene editing to reverse inherited kidney disease in preclinical study featured image · Rewriting the future of rheumatoid arthritis: How early ...
PHOENIX — Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, helping explain why ...
Julie Ferris-Tillman, Ph.D. February 11, 2026. Advancing epilepsy care: Mayo Clinic neurologist Dr. Gregory Worrell featured image.
ROCHESTER, Minn. — Photon therapy offers strong outcomes in treating oropharyngeal cancers; however, some radiation can reach and damage nearby healthy ...
Considered the most aggressive type of brain cancer, glioblastoma grows rapidly, destroying healthy tissue. Globally, approximately 300,000 people are diagnosed ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.